Multiple Tests with Single Small Blood Sample

Affordable, Accurate, Efficient and Flexible



Our new differentiated assay is alpha clinical trial stage.

One test can detect both the Spike protein and the Nucleocapsid protein!

Enquire for more information


Detection Addition Control Spots
SARS-CoV-2 NP IgG Antibody detection spots 
SARS-CoV-2 SP IgG Antibody detection spots 
Blank Control Spots

Detects both Spike and Nucleocapsid proteins

Sample size is 1:101 serum dilution

Email to express interest in performing an LDT or to be advised when manufacturing has commenced.



ToRCH describes a group of clinically similar congenital infections caused by Toxoplasma gondii, Rubella, CMV and HSV1 and HSV2.

Infections with one of these pathogens during pregnancy can have devastating consequences in the infant. Pregnant women in developing countries are commonly tested for antibodies to ToRCH antigens during the first two trimesters of pregnancy.

Detection Addition Control Spots
Sample Addition Control
Conjugate G/M Addition Control
Conjugate M Addition Control
Blank Control Spots
Toxoplasma Gondii
Cytomegalovirus (CMV)
Herpes Simplex Virus 1 (HSV 1)
Herpes Simplex Virus 2 (HSV 2)

Detects IgG/IgM antibodies
Requires only 5–10µl serum sample
Sensitivity ≥ 90% & Specificity ≥ 95%
Shelf Life–13 months

PICT_TRH_01 (16 Tests)
PICT_TRH_03 (48 Tests)
PICT_TRH_06 (96 Tests)